You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anticancer Activities

Showing 1 - 25 of 6,957
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Cancer Stage IV, HER2-negative Breast Cancer Trial in United States (Mirdametinib, Fulvestrant)

Recruiting
  • Breast Cancer
  • +6 more
  • Middletown, New Jersey
  • +3 more
Dec 28, 2021

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral

Completed
  • Hepatocellular Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Acral Melanoma, Mucosal Melanoma Trial in Seoul (Pembrolizumab, Vactosertib)

Not yet recruiting
  • Acral Melanoma
  • Mucosal Melanoma
  • Pembrolizumab, Vactosertib
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jun 23, 2022

Cachexia Trial in Taichung, Taipei (fucoidan)

Recruiting
  • Cachexia
  • fucoidan
  • Taichung, Please Select, Taiwan
  • +1 more
Nov 13, 2022

Colorectal Cancer, GIST Trial (DCC-3116, Ripretinib, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • GIST
  • (no location specified)
Jul 14, 2023

Impact of COVID-19 on Lung Cancer Patients

Completed
  • Lung Cancer
  • +3 more
  • questionnaire and optional interview
  • Manchester, United Kingdom
    The Christie NHS Foundation
Aug 30, 2022

Soft Tissue Infections, Gingival Recession Trial in Assiut (hydroxylate flavones solid dispersion application, Placebo)

Not yet recruiting
  • Soft Tissue Infections
  • Gingival Recession
  • hydroxylate flavones solid dispersion application
  • Placebo
  • Assiut, Egypt
    Assiut University
Apr 13, 2023

EXploring Immune-related Adverse Events of Immune checkpoinT

Active, not recruiting
  • Cancer
  • +2 more
  • Immune checkpoint inhibitor
  • Paris, France
  • +1 more
Jul 5, 2023

Melanoma Trial in Worldwide (encorafenib, binimetinib, pembrolizumab)

Recruiting
  • Melanoma
  • Siena, Toscana, Italy
  • +11 more
Jun 23, 2023

Liposarcoma, Dedifferentiated Trial (Brigimadlin)

Not yet recruiting
  • Liposarcoma, Dedifferentiated
  • (no location specified)
Sep 22, 2023

Acute Cardiovascular Adverse Events Occuring in Children Treated

Not yet recruiting
  • Malignancies
  • +2 more
  • use of anticancer drugs in monotherapy or in combination therapy
  • (no location specified)
Oct 27, 2022

Breast Tumors Trial in Japan (E7090, Fulvestrant, Exemestane)

Recruiting
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +10 more
Nov 11, 2022

Lymphoma, Non-Hodgkin, Hodgkin Lymphoma Trial in Worldwide (AZD3470)

Not yet recruiting
  • Lymphoma
  • +2 more
  • Miami, Florida
  • +10 more
Nov 13, 2023

Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

Not yet recruiting
  • Non-Muscle- Invasive Bladder Cancer
  • Durvalumab
  • BCG
  • (no location specified)
Jul 5, 2023

Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Placebo Oral Tablet)

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Scottsdale, Arizona
  • +34 more
Nov 17, 2022

Non Small Cell Lung Cancer Trial in Seoul (Lazertinib+Pemetrexed+Carboplatin, Lazertinib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Aug 31, 2023

BTK Inhibitors-related AF Treated by Catheter Ablation

Not yet recruiting
  • BTKi-induced Atrial Fibrillation
  • +2 more
  • Atrial fibrillation catheter ablation in a population of BTKi-induced atrial fibrillation
  • Caen, Normandy, France
    Caen University Hospital
Nov 10, 2023

Breast Tumor Trial in Toulouse (APA Program, Recommendations for physical activity)

Not yet recruiting
  • Breast Neoplasm
  • APA Program
  • Recommendations for physical activity
  • Toulouse, France
    Marie-Eve Rougé-Bugat
Jul 17, 2023

Hepatocellular Carcinoma, Biliary Tract Cancer Trial in Worldwide (MEDI5752, Bevacizumab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Biliary Tract Cancer
  • Birmingham, Alabama
  • +44 more
Mar 17, 2023

Cosmetic Product on Xerosis Induced by Systemic Anticancer

Recruiting
  • Xerosis
  • Cosmetic product
  • Cahors, France
  • +3 more
Apr 1, 2021

Breast Tumors Trial in Granada (ATOPE-B, ATOPE-I)

Recruiting
  • Breast Neoplasms
  • ATOPE-B
  • ATOPE-I
  • Granada, Spain
    University of Granada
May 25, 2022

Differentiated Thyroid Cancer Trial in Spain (Cabozantinib)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Oviedo, Asturias, Spain
  • +9 more
Dec 14, 2022

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine)

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab Soravtansine
  • Phoenix, Arizona
  • +88 more
Jan 19, 2023

Cancer Trial in Genova (Short-term modified fasting)

Recruiting
  • Cancer
  • Short-term modified fasting
  • Genova, Italy
    San Martino Hospital
Feb 17, 2023

Metastatic Castration-Resistant Prostate Cancer Trial in United States (XmAb20717 + carboplatin + cabazitaxel, XmAb20717 +

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • XmAb20717 + carboplatin + cabazitaxel
  • +2 more
  • Duarte, California
  • +9 more
May 24, 2022